SEC Form 4 · accession 0001140361-16-056914
ARDELYX, INC. · ARDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P. Rosenbaum
Officer — SVP, Drug Development
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 9:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437402
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Mar 3, 2016 | S | 1,128 | $10.7357 | D | 22,144 | D | |
| Common StockF4 | holding | — | — | — | 77,592 | I | See Footnote | |
| Common StockF5,F6 | holding | — | — | — | 1,536 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2015.
- F2This transaction was executed in multiple trades in prices ranging from $10.66 to $10.88, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3Includes 1,332 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016.
- F4The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
- F5Consists of 1,536 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016.
- F6The shares are directly held by the Reporting Person's wife.